Tag: Glutamate carboxypeptidase II

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Glutamate carboxypeptidase II

Lantheus-POINT Biopharma Ink Strategic Collaboration For Cancer Programs - Benzinga

Added to Collection on: 2022-11-14 20:01:45

Tags for this article:

Physical sciences
Branches of biology
Chemistry
Infectious causes of cancer
Pancreatic cancer
Radiopharmaceuticals
Neuroendocrine tumor
Neuroendocrinology
Glutamate carboxypeptidase II
MCRPC
Lutetium
Prostate cancer
Lantheus Holdings Inc

Click the tags to see associated articles and topics

View Article Details
Lantheus and POINT Biopharma Announce Strategic - GlobeNewswire

Added to Collection on: 2022-11-14 18:01:48

Tags for this article:

Branches of biology
Physical sciences
Health
Radiopharmaceuticals
Glutamate carboxypeptidase II
Molecular neuroscience
Neurotransmitters
Peptidase
Prostate cancer
Forward-looking statement
Pharmaceutical industry in China
MCRPC
Lantheus Holdings Inc

Click the tags to see associated articles and topics

View Article Details
New Data on POSLUMA® (Flotufolastat F 18) in Patients with Suspected ... - Yahoo Finance

Added to Collection on: 2023-10-03 06:20:17

Tags for this article:

Prostate cancer
Medicinal radiochemistry
Medical physics
Radiation therapy
Neuroimaging
Prostate-specific antigen
Glutamate carboxypeptidase II
Radiopharmaceutical
Molecular imaging
Biochemical recurrence
Positron emission tomography
Prostate
Blue Earth Diagnostics
Bracco Group

Click the tags to see associated articles and topics

View Article Details
Real-world data highlight clinical benefit of 177Lu-PSMA-617 in mCRPC - Urology Times

Added to Collection on: 2024-02-05 21:18:12

Tags for this article:

Prostate cancer
Radiation therapy
Radiopharmaceuticals
Lutetium (177Lu) vipivotide tetraxetan
Gallium
Radium-223
PSMA scan
Glutamate carboxypeptidase II

Click the tags to see associated articles and topics

View Article Details
Study launches of BNT316/ONC-392 plus radioligand therapy in mCRPC - Urology Times

Added to Collection on: 2024-02-22 21:08:48

Tags for this article:

Radiopharmaceuticals
Prostate cancer
Lutetium (177Lu) vipivotide tetraxetan
Lutetium
Glutamate carboxypeptidase II
Androgen deprivation therapy
Advanced Accelerator Applications
PSMA scan
OncoC4 Inc.

Click the tags to see associated articles and topics

View Article Details
OncoC4 Announces First Patient with Advanced Prostate Cancer Dosed in Phase 1/2 ... - Morningstar

Added to Collection on: 2024-02-22 13:17:50

Tags for this article:

Prostate cancer
Lutetium (177Lu) vipivotide tetraxetan
Radiopharmaceuticals
Glutamate carboxypeptidase II
Targeted therapy
Cancer treatment
Prostvac
Advanced Accelerator Applications
OncoC4 Inc.
BioNTech

Click the tags to see associated articles and topics

View Article Details
OncoC4 Announces First Patient with Advanced Prostate - GlobeNewswire

Added to Collection on: 2024-02-22 13:14:51

Tags for this article:

Prostate cancer
Lutetium (177Lu) vipivotide tetraxetan
Radiopharmaceuticals
Glutamate carboxypeptidase II
Targeted therapy
Cancer treatment
Prostvac
Advanced Accelerator Applications
OncoC4 Inc.
BioNTech

Click the tags to see associated articles and topics

View Article Details
Fusion Pharmaceuticals Announces Presentation of Interim Data from the Phase 2 TATCIST ...

Added to Collection on: 2024-04-09 20:06:17

Tags for this article:

Prostate cancer
Radiopharmaceuticals
Lutetium (177Lu) vipivotide tetraxetan
Glutamate carboxypeptidase II
Lutetium
PSMA scan
Fusion Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
Biotech acquisition trend: radiopharmaceuticals - Taylor Wessing

Added to Collection on: 2024-05-08 14:38:17

Tags for this article:

Medicinal radiochemistry
Radiobiology
Medical isotopes
Radiation therapy
Medical physics
Advanced Accelerator Applications
Radiopharmaceutical
Radiopharmacology
Algeta
Endocyte
Glutamate carboxypeptidase II
Technetium-99m

Click the tags to see associated articles and topics

View Article Details
Convergent Therapeutics Announces First Shipments of Actinium 225 from Cardinal Health ...

Added to Collection on: 2024-11-19 18:17:21

Tags for this article:

Immunology
Prostate cancer
Biotechnology
Immune system
Radiation therapy
Glutamate carboxypeptidase II
Antibody
Monoclonal antibody
Cancer
Radioligand
PSMA scan
Convergent Therapeutics Inc.
Ac-225

Click the tags to see associated articles and topics

View Article Details